Murphy J G, Steckelberg J M
Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Curr Opin Cardiol. 1995 Mar;10(2):150-4. doi: 10.1097/00001573-199503000-00009.
Endocarditis as seen today differs significantly from that outlined by Sir William Osler in his famous Gulstonian lectures in 1885. The median age of the patients has increased; the spectrum of predisposing cardiac lesions has changed; more cases are due to unusual organisms, including gram-negative bacteria and fungi; and more cases present acutely and the classic findings of late endocarditis are seldom seen. Endocarditis was untreatable and uniformly fatal in 1885. Although continued advances in medical and surgical therapy have significantly increased survival, the recent appearance of multiresistant organisms in some cases is reminiscent of the Osler era. Recent advances in the diagnosis and management of endocarditis include the identification of a specific Staphylococcus aureus receptor protein on endothelial cells, better imaging of the cardiac structures using transesophageal echocardiography, improvement in clinical diagnostic criteria and surgical techniques, and the use of outpatient oral antibiotics for penicillin-sensitive streptococcal endocarditis.
如今所见的心内膜炎与1885年威廉·奥斯勒爵士在其著名的古尔斯顿讲座中所描述的有显著不同。患者的中位年龄增加了;易患心脏病变的范围发生了变化;更多病例是由不常见的病原体引起的,包括革兰氏阴性菌和真菌;更多病例呈急性发作,很少见到晚期心内膜炎的典型表现。1885年,心内膜炎无法治疗且无一例外是致命的。尽管医学和外科治疗的持续进步显著提高了生存率,但最近在某些病例中出现的多重耐药病原体让人想起奥斯勒时代。心内膜炎诊断和治疗的最新进展包括在内皮细胞上鉴定出一种特定的金黄色葡萄球菌受体蛋白、使用经食管超声心动图对心脏结构进行更好的成像、临床诊断标准和外科技术的改进,以及对青霉素敏感的链球菌性心内膜炎使用门诊口服抗生素。